Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Diagnostic Context

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05527977Not ApplicableCompleted

Clinical Documentation Physician Compensation Incentives

NCT04825106Not ApplicableCompletedPrimary

Diagnostic Errors in Anaphylactic Shock

NCT05760859Not ApplicableCompletedPrimary

Quality of Medical History Taking and Diagnostic Accuracy

Showing all 3 trials

Research Network

Common Treatments

  • Diagnostic Context1
  • Compensation Incentives To Improve Clinical Documentation1
  • Initial Cue1

Active Sponsors

  • University Hospital, Basel, Switzerland2
  • Rush University Medical Center1

Top Investigators

Related Conditions

  • Compensation Incentives1
  • Clinical Documentation1
  • Physician Work Environment1

Activity Timeline